Regeneron Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Regeneron Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 20, 2026	Think Bioscience	$55.0M Series A	Nick Olsen, Janus Henderson Investors, Regeneron Ventures	T.A. Springer, AV8 Ventures, Buff Gold Ventures, CE Ventures, CU Healthcare Innovation Fund, MBX Capital, YK Bioventures
Dec 21, 2025	Atavistik Bio	$120.0M Series B	Nextech Invest, The Column Group	Lux Capital
Dec 3, 2025	Triana Biomedicines	$120.0M Series B	Lorence Kim, Andrew Hedin	Atlas Venture, Finchley Healthcare Ventures, Invus, Lightspeed Venture Partners, RA Capital Management, Surveyor Capital, YK Bioventures
Nov 10, 2025	Iambic Therapeutics	$100.0M Other Equity	—	Abingworth, Alexandria Venture Investments, Alumni Ventures, ARK Invest, Ascenta Capital, Catalio Capital Management, Everbright Biofund, Freeflow Ventures, Illumina Ventures, Pegasus Tech Ventures, Qatar Investment Authority, Sequoia Capital, Tao Capital Partners, Terra Magnum Capital Partners, Wilson Sonsini Goodrich & Rosati
Aug 1, 2025	Strand Therapeutics	$150.0M Series B	Kinnevik	Decibel Partners, FPV Fund, Mozilla Ventures, Northzone, Playground Global, RRE Ventures, Sands Capital, Sapphire Ventures, Tiger Global Management, Work-Bench, Amgen Ventures, ANRI, Eli Lilly and Company, FPV Ventures, Freepoint Capital Group, Gradiant Corporation, ICONIQ Growth, JIC Venture Growth Investments, LG Technology Ventures, Potentum Partners
Jun 1, 2025	Actio Biosciences	$66.0M Series B	Deerfield Management, Regeneron Ventures	Canaan Partners, Canaan Partners, Droia Ventures, Euclidean Capital
Dec 1, 2024	Tasca	$67.0M Series A	David Fallace, Regeneron Ventures	SOSV
Apr 1, 2024	Enlaza Therapeutics	$100.0M Series A	Stephen Squinto	.406 Ventures, Ascension Ventures, Atlas Venture, Avalon Ventures, Frazier Healthcare Partners, OrbiMed, Samsara BioCapital, Alexandria Venture Investments, Amgen Ventures, Bregua Corporation, James Topper, Shelley Chu, Pappas Capital